7.82
price down icon5.75%   -0.51
 
loading
Precedente Chiudi:
$8.33
Aprire:
$7.76
Volume 24 ore:
92,662
Relative Volume:
0.19
Capitalizzazione di mercato:
$143.67M
Reddito:
$62.81M
Utile/perdita netta:
$-13.75M
Rapporto P/E:
-9.775
EPS:
-0.8
Flusso di cassa netto:
$153.00K
1 W Prestazione:
-10.17%
1M Prestazione:
+61.22%
6M Prestazione:
+0.27%
1 anno Prestazione:
-29.71%
Intervallo 1D:
Value
$7.68
$8.145
Intervallo di 1 settimana:
Value
$7.68
$8.94
Portata 52W:
Value
$3.78
$14.13

Optimizerx Corp Stock (OPRX) Company Profile

Name
Nome
Optimizerx Corp
Name
Telefono
248-651-6558
Name
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Name
Dipendente
0
Name
Cinguettio
@OpRxTweets
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
OPRX's Discussions on Twitter

Confronta OPRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
OPRX
Optimizerx Corp
7.85 143.67M 62.81M -13.75M 153.00K -0.80
Health Information Services icon
VEEV
Veeva Systems Inc
223.97 36.00B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
DOCS
Doximity Inc
54.86 10.33B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
TEM
Tempus Ai Inc
46.50 8.16B 640.44M -743.28M -206.93M -11.29
Health Information Services icon
HQY
Healthequity Inc
84.49 7.17B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
36.49 6.24B 906.14M -52.62M 89.62M -0.3621

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-08 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-12-20 Iniziato Stephens Equal-Weight
2024-07-25 Ripresa B. Riley Securities Buy
2024-04-04 Iniziato JMP Securities Mkt Outperform
2024-01-03 Iniziato Barclays Equal Weight
2023-02-02 Ripresa B. Riley Securities Buy
2022-11-01 Iniziato Stifel Buy
2022-07-15 Iniziato SVB Leerink Outperform
2021-10-18 Ripresa B. Riley Securities Buy
2021-04-13 Iniziato RBC Capital Mkts Outperform
2019-01-03 Iniziato William Blair Outperform
Mostra tutto

Optimizerx Corp Borsa (OPRX) Ultime notizie

pulisher
Apr 02, 2025

Blair William & Co. IL Reduces Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat

Apr 02, 2025
pulisher
Mar 30, 2025

OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company - Yahoo Finance

Mar 30, 2025
pulisher
Mar 29, 2025

Bank of New York Mellon Corp Has $426,000 Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

OptimizeRx Files $75 Million Mixed Shelf - Marketscreener.com

Mar 28, 2025
pulisher
Mar 28, 2025

OptimizeRx Corp Files For Mixed Shelf Of Up To $75 MillionSEC Filing - MarketScreener

Mar 28, 2025
pulisher
Mar 24, 2025

OptimizeRx Co. (NASDAQ:OPRX) Director James Paul Lang Purchases 321,408 Shares - MarketBeat

Mar 24, 2025
pulisher
Mar 24, 2025

Royce & Associates LP Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat

Mar 24, 2025
pulisher
Mar 22, 2025

OptimizeRx Corp (NASDAQ: OPRX): The Metrics That Matter Right Now - Stocks Register

Mar 22, 2025
pulisher
Mar 22, 2025

OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 22, 2025
pulisher
Mar 20, 2025

OptimizeRx Corp SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

What is B. Riley's Estimate for OptimizeRx Q1 Earnings? - MarketBeat

Mar 20, 2025
pulisher
Mar 19, 2025

OptimizeRx director James Lang purchases $2.44 million in common stock By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

OptimizeRx director James Lang purchases $2.44 million in common stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Head to Head Review: OptimizeRx (NASDAQ:OPRX) & CFN Enterprises (OTCMKTS:CNFN) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Why OptimizeRx Corp. (OPRX) Soared Last Week? - Insider Monkey

Mar 17, 2025
pulisher
Mar 17, 2025

OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

What is B. Riley’s Estimate for OptimizeRx Q1 Earnings? - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

Roth Capital Predicts OptimizeRx's Q1 Earnings (NASDAQ:OPRX) - MarketBeat

Mar 17, 2025
pulisher
Mar 17, 2025

Research Analysts Issue Forecasts for OptimizeRx Q1 Earnings - Defense World

Mar 17, 2025
pulisher
Mar 16, 2025

OptimizeRx (NASDAQ:OPRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat

Mar 16, 2025
pulisher
Mar 15, 2025

OptimizeRx (NASDAQ:OPRX) Upgraded at B. Riley - MarketBeat

Mar 15, 2025
pulisher
Mar 13, 2025

OptimizeRx Corp [OPRX] CEO makes an insider purchase of 20,000 shares worth 0.1 million. - Knox Daily

Mar 13, 2025
pulisher
Mar 13, 2025

OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 13, 2025
pulisher
Mar 13, 2025

OptimizeRx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion - Investing.com Canada

Mar 13, 2025
pulisher
Mar 12, 2025

OptimizeRx Q4 results ‘at odds with muted’ outlook, says Roth MKM - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million - Benzinga

Mar 12, 2025
pulisher
Mar 12, 2025

Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

OPTIMIZERx earnings beat by $0.04, revenue topped estimates - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges - Investing.com UK

Mar 12, 2025
pulisher
Mar 12, 2025

OptimizeRx Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

ForexTV | Small Business Resources - ForexTV.com

Mar 12, 2025
pulisher
Mar 11, 2025

OptimizeRx receives board nomination notice from Whetstone By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

OptimizeRx receives board nomination notice from Whetstone - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

OptimizeRx confirms receipt of notice of director nominations - MSN

Mar 11, 2025
pulisher
Mar 11, 2025

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

OPTIMIZERx receives director nominations from Whetstone Capital Advisors -March 11, 2025 at 07:42 am EDT - MarketScreener

Mar 11, 2025
pulisher
Mar 11, 2025

OptimizeRx Faces Board Shakeup as Activist Investor Pushes for Change - StockTitan

Mar 11, 2025
pulisher
Mar 10, 2025

OptimizeRx appoints Steve Silvestro as new CEO By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

OptimizeRx appoints Steve Silvestro as new CEO - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer - The Manila Times

Mar 10, 2025
pulisher
Mar 10, 2025

OPTIMIZERx appoints Stephen Silvestro as CEO -March 10, 2025 at 07:42 am EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

OptimizeRx Promotes CCO Steve Silvestro to Chief Executive Officer - StockTitan

Mar 10, 2025
pulisher
Mar 10, 2025

OptimizeRx (OPRX) Expected to Announce Earnings on Wednesday - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

OptimizeRx (OPRX) to Release Earnings on Wednesday - MarketBeat

Mar 08, 2025

Optimizerx Corp Azioni (OPRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$9.81
price down icon 4.11%
$4.46
price up icon 0.00%
$19.37
price down icon 0.15%
$21.47
price down icon 2.33%
$17.26
price down icon 3.69%
health_information_services WAY
$35.83
price down icon 3.70%
Capitalizzazione:     |  Volume (24 ore):